Navigation Links
Tamaulipas Comparative Wound Healing Test Treatment Successfully Concluded
Date:10/29/2009

WITTEN, Germany, October 29 /PRNewswire-FirstCall/ -- The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons. 22 of the 24 patients within the Hemospray group were healed completely, while 22 of the 24 patients of the control group showed no comparable progress. Moreover, additional patients suffering from diabetic foot disease were successfully treated with Hemospray. The total healing ratio is significantly higher than 75%.

These results were presented to health system representatives of several Latin American countries in Mexico City by the Chief Investigator of the study.

The results are currently being evaluated by the State Health Authorities of Tamaulipas who sponsored the study.

Apart from this, a considerable share of the patient data were crosschecked and evaluated by Sangui in Witten. It turned out that these data confirm the results as previously indicated. Sangui regards this outcome as a confirmation of the outstanding efforts made by the teams on location and as a great success of its systematic competence in wound healing.

SanguiBioTech GmbH is a ninety percent subsidiary of Sangui BioTech International, Inc. (http://www.pinksheets.com: SGBI)

Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    For more information please contact:

    Joachim Fleing
    Phone: +49(160)741-27-17
    Fax: +49(2302)915-191
    e-mail: fleing@sangui.de


SOURCE Sangui Bio Tech International Inc.


'/>"/>
SOURCE Sangui Bio Tech International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
2. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
3. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
4. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
5. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
6. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
7. Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference
8. Wound Management Technologies Acquires Resorbable Orthopedics
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. New Data Supports ConvaTec Negative Pressure Wound Therapy
11. New Powder Speeds Healing of Difficult Foot Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):